41. Pityriasis alba

go back to reference Vinod S, Singh G, Dash K, Grover S. Clinico epidemiological study of pityriasis alba. Indian J Dermatol Venereol Leprol 2002;68:338-40. Vinod S, Singh G, Dash K, Grover S. Clinico epidemiological study of pityriasis alba. Indian J Dermatol Venereol Leprol 2002;68:338-40.

go back to reference Miazek N, Michalek I, Pawlowska-Kisiel M, Olszewska M, Rudnicka L. Pityriasis alba – common disease, enigmatic entity: up-to-date review of the literature. Pediatr Dermatol 2015;32:786-91.CrossRef Miazek N, Michalek I, Pawlowska-Kisiel M, Olszewska M, Rudnicka L. Pityriasis alba – common disease, enigmatic entity: up-to-date review of the literature. Pediatr Dermatol 2015;32:786-91.CrossRef

go back to reference Blessmann Weber M, Sponchiado de Ávila LG, Albaneze R, Magalhães de Oliveira OL, Sudhaus BD, Cestari T. Pityriasis alba: a study of pathogenetic factors. J Eur Acad Dermatol Venereol 2002;16:463-8.CrossRef Blessmann Weber M, Sponchiado de Ávila LG, Albaneze R, Magalhães de Oliveira OL, Sudhaus BD, Cestari T. Pityriasis alba: a study of pathogenetic factors. J Eur Acad Dermatol Venereol 2002;16:463-8.CrossRef

go back to reference Lin RL, Janniger CK. Pityriasis alba. Cutis 2005;76:21-4. Lin RL, Janniger CK. Pityriasis alba. Cutis 2005;76:21-4.

go back to reference van Puijenbroek EP, Duyvendak RJP, de Kock CA, et al. NHG-Standaard Dermatomycosen (Eerste herziening). Huisarts Wet 2008;51:76-84. https://www.nhg.org/standaarden/volledig/nhg-standaard-dermatomycosen, geraadpleegd juli 2016. van Puijenbroek EP, Duyvendak RJP, de Kock CA, et al. NHG-Standaard Dermatomycosen (Eerste herziening). Huisarts Wet 2008;51:76-84. https://​www.​nhg.​org/​standaarden/​volledig/​nhg-standaard-dermatomycosen, geraadpleegd juli 2016.

go back to reference Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol 2007;46:700-5. Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol 2007;46:700-5.

go back to reference Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol 2006;155:152-5. Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol 2006;155:152-5.

go back to reference Patrizi A, Raone B, Raboni R, Neri I. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba: A double-blind, placebo-controlled clinical trial. G Ital Dermatol Venereol 2012;147:1-8. Patrizi A, Raone B, Raboni R, Neri I. Efficacy and tolerability of a cream containing AR-GG27^® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba: A double-blind, placebo-controlled clinical trial. G Ital Dermatol Venereol 2012;147:1-8.

go back to reference Di Lernia V, Ricci C. Progressive and extensive hypomelanosis and extensive pityriasis alba: same disease, different names? J Eur Acad Dermatol Venereol 2005;19:370-2.CrossRef Di Lernia V, Ricci C. Progressive and extensive hypomelanosis and extensive pityriasis alba: same disease, different names? J Eur Acad Dermatol Venereol 2005;19:370-2.CrossRef